Susquehanna Starts Mylan (MYL), Watson (WPI) at Positive, Teva (TEVA) at Neutral

An analyst at Susquehanna initiated coverage on several Pharma names late Wednesday afternoon:

• Mylan (NYSE: MYL) with a Positive rating and $30 price target
  
• Watson Pharma (NYSE: WPI) with a Positive rating and $72 price target
  
• Teva Pharma (Nasdaq: TEVA) with a Neutral rating and a $48 price target

Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Needham Starts Faeth Therapeutics (FTH) at Buy
• Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
• William Blair Starts Tandem Diabetes Care (TNDM) at Outperform